http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201590062-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295 |
| filingDate | 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201590062-A1 |
| titleOfInvention | APPLICATION OF LEMON-ACID IRON IN THE TREATMENT OF PATIENTS WITH CHRONIC RENOVAL INSUFFICIENCY |
| abstract | Methods for administering citric acid iron to reduce and / or control blood phosphorus levels, increase serum bicarbonate levels, increase one or more iron accumulation parameters (eg, increase serum ferritin concentration, increase transferrin saturation (TSAT), hemoglobin), increase iron absorption, maintain iron reserves in the body, treat iron deficiency, treat anemia, reduce the need for iron IV and / or reduce the need for erythropoiesis stimulator constituent substances (ESA) in patients with chronic renal failure patients. |
| priorityDate | 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.